rare kidney diseases

Israeli Protalix Partners With Germany’s Secarna on Rare Kidney Disease Therapies

Israeli Protalix BioTherapeutics partners with Germany’s Secarna Pharmaceuticals to develop rare kidney disease therapies, leveraging AI for drug candidate.